Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
Centro de investigación
University of the Witwatersrand
Johannesburgo, SudáfricaPublicacións en colaboración con investigadores/as de University of the Witwatersrand (67)
2024
-
Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023
Nature Medicine, Vol. 30, Núm. 6, pp. 1559-1563
-
The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus
Nature communications, Vol. 15, Núm. 1, pp. 3083
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Age Differences in Comorbidities, Presenting Symptoms, and Outcomes of Influenza Illness Requiring Hospitalization: A Worldwide Perspective From the Global Influenza Hospital Surveillance Network
Open Forum Infectious Diseases
-
Diminishing benefits of urban living for children and adolescents’ growth and development
Nature, Vol. 615, Núm. 7954, pp. 874-883
-
Genomic investigations of unexplained acute hepatitis in children
Nature, Vol. 617, Núm. 7961, pp. 564-573
-
Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
Nature Medicine, Vol. 29, Núm. 11, pp. 2885-2901
-
Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data
The Lancet Infectious Diseases, Vol. 23, Núm. 7, pp. 856-866
2022
-
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
The Lancet, Vol. 399, Núm. 10340, pp. 2047-2064
-
Identifying the research, advocacy, policy and implementation needs for the prevention and management of respiratory syncytial virus lower respiratory tract infection in low- and middle-income countries
Frontiers in Pediatrics, Vol. 10
-
IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms
Journal of Clinical Medicine, Vol. 11, Núm. 19
-
Improving empiric antibiotic prescribing in pediatric bloodstream infections: a potential application of weighted-incidence syndromic combination antibiograms (WISCA)
Expert Review of Anti-Infective Therapy, Vol. 20, Núm. 3, pp. 445-456
2021
-
Association of Rare CYP39A1 Variants with Exfoliation Syndrome Involving the Anterior Chamber of the Eye
JAMA - Journal of the American Medical Association, Vol. 325, Núm. 8, pp. 753-764
-
Body mass index and disease activity in chronic inflammatory rheumatic diseases: Results of the cardiovascular in rheumatology (CARMA) project
Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-10
-
Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-up
Rheumatology (Oxford, England), Vol. 60, Núm. 6, pp. 2906-2915
-
Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight
eLife, Vol. 10
-
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants
Obstetrical and Gynecological Survey
-
Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome
Scientific Reports, Vol. 11, Núm. 1
-
Treatment with tofacitinib in refractory psoriatic arthritis: A national multicenter study of the first 87 patients in clinical practice
Journal of Rheumatology, Vol. 48, Núm. 10, pp. 1552-1558
2020
-
Complicated hospitalization due to influenza: Results from the Global Hospital Influenza Network for the 2017-2018 season
BMC Infectious Diseases, Vol. 20, Núm. 1